(Q53216728)

English

The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targeting caspase.

scientific article published on 27 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targeting caspase. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

1 reference

based on heuristic

inferred from title

author name string

Jung-Lim Kim

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

Han-Na Kang

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

Myoung Hee Kang

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

Young A Yoo

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

Jun Suk Kim

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

Chul Won Choi

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

publication date

27 September 2011

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

Acta Haematologica

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

126

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

241-245

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

Iron chelators induce apoptosis in proliferating cells

1 reference

https://api.crossref.org/works/10.1159%2F000330608

21 January 2018

Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.

1 reference

https://api.crossref.org/works/10.1159%2F000330608

21 January 2018

Iron chelators as therapeutic agents for the treatment of cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000330608

21 January 2018

Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism

1 reference

https://api.crossref.org/works/10.1159%2F000330608

21 January 2018

The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox

1 reference

https://api.crossref.org/works/10.1159%2F000330608

21 January 2018

The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1.

1 reference

https://api.crossref.org/works/10.1159%2F000330608

21 January 2018

Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

1 reference

https://api.crossref.org/works/10.1159%2F000330608

21 January 2018

Identifiers

10.1159/000330608

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21951998

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53216728&oldid=1239879273"